4 Selected information follows for Blossom Corporation for three independent situations: Blossom purchased a patent from Bakhshi Co. for $1.6 million on January 1, 2015. The patent expires on January 1, 2025, and Blossom is amortizing it over the 10 years remaining in its legal life. During 2017, Blossom determined that the patent's economic benefits would not last longer than six years from the date of acquisition. What amount should be reported in the statement of financial position for the patent, net of accumulated amortization, at December 31, 2017? Patent, net of accumulated amortization $ LINK TO TEXT LINK TO TEXT LINK TO TEXT LINK TO TEXT Blossom bought a perpetual franchise from Carmody Inc. on January 1, 2017, for $600,000. Its carrying amount on Carmody's books at January 1, 2017, was $720,000. Assume that Blossom can only provide evidence of clearly identifiable cash flows for 25 years, but thinks the franchise could have value for up to 60 years. What amount of amortization expense should be reported for the year ended December 31, 2017? Amortization expense $ LINK TO TEXT LINK TO TEXT LINK TO TEXT LINK TO TEXT On January 1, 2015, Blossom incurred development costs (meeting all required criteria) of $365,000. Blossom is amortizing these costs over five years. What amount, if any, should be reported as unamortized development costs as at December 31, 2017? Unamortized development costs $ How might the accounting treatment change if Blossom were using ASPE? (If an answer is zero, please enter 0. Do not leave any fields blank.) Unamortized development costs